Pharma Inc. Astellas serves as Executive at Sucampo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Pharma Inc. Astellas has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 19, 2014 involved exercising options for 4,968,367 shares valued at $0.
Pharma Inc. Astellas currently holds 4,968,367 shares of Sucampo Pharmaceuticals, Inc. (SCMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma Inc. Astellas has been a net neutral trader of SCMP stock. They have purchased $0 and sold $0 worth of shares.
Pharma Inc. Astellas's most recent insider trade was on Nov 19, 2014, when they sold 4,968,367 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |